MAX Surgical Specialty Management Enters New York City in Landmark Partnership with Manhattan's Top Oral Surgeons

HACKENSACK, N.J., Oct. 7, 2025 /PRNewswire/ -- MAX Surgical Specialty Management (MAX), the leading surgeon-led platform for oral and maxillofacial surgery (OMS) in the Northeast, today announced its expansion into New York City through a landmark partnership with one of Manhattan's most respected practices: New York Oral & Maxillofacial Surgery and Dental Implant Center.

This milestone signals not just a geographic expansion but a validation of MAX's philosophy of building a model where surgical mastery and operational excellence are not mutually exclusive. New York City is the country's most competitive healthcare market, and MAX's entrance, via a partnership with two nationally recognized leaders, affirms the power of a platform built by surgeons, for surgeons.

"This isn't just another partnership. This is the partnership," said Jason M. Auerbach, DDS, Founder and Co-CEO of MAX. "When two of the most notable oral surgeons in the city choose MAX, it tells you something. We're not here to dictate; we're here to elevate. Autonomy, innovation, and legacy aren't talking points. They're our standard."

Through this partnership, David Koslovsky, DDS, FACS, FACD and Mark Stein, DDS, MD, both widely recognized for their contributions to the field, join the MAX network. Their Manhattan-based practice is known for its surgical expertise, cutting-edge technology, and commitment to patient experience.

"Drs. Stein and Koslovsky are among the most renowned voices in our field. They represent the highest level of clinical excellence and leadership," said Mark Censoprano, Co-CEO of MAX. "Their decision to join MAX reinforces our belief that the best surgeons want a partner—not a parent company."

"We've gotten here by relentlessly pursuing clinical excellence and innovation," said Dr. Stein. "We chose MAX because they value the reputation we've built and are committed to safeguarding our clinical autonomy. MAX gives Dr. Koslovsky and I the backing to reach the next level without compromise while we stay free to push surgical boundaries and elevate patient care."

Founded in 2022, MAX curates a powerful network of surgeon-partners across the Northeast, uniting top-tier clinical talent with high-touch operational support. Its growth has been driven by proximity, peer connection, and performance. Since 2023, MAX has seen double-digit increases in production, collections, and patient volume across its practices. The surgeon network expanded by nearly 60 percent, and its geographic footprint now extends to five states.

Dr. David Koslovsky
Dr. Koslovsky is a board-certified oral and maxillofacial surgeon whose compassionate bedside manner is complemented by a concierge-minded approach to patient care. With a distinguished 15-year career in New York City, he is known as a trusted surgeon for complex oral and maxillofacial conditions in adults and children. Blending academic precision with personalized care, his practice offers office- and hospital-based procedures, providing a tailored experience across a full spectrum of surgical needs. His expertise includes custom orthognathic (corrective jaw) surgery, genioplasty, complex wisdom teeth removal, advanced bone grafting, guided dental implants, and management of facial and jaw fractures and pathology.

After earning degrees from Brandeis University and Columbia University, Dr. Koslovsky completed his residency at the Albert Einstein College of Medicine. A nationally recognized lecturer, he has authored more than 20 publications. He serves on the faculties of Weill Cornell Medical College and Columbia University College of Dental Medicine, and holds admitting and surgical privileges at Columbia, Cornell, and Montefiore Hospitals.

Dr. Mark Stein
Dr. Stein is a board-certified oral and maxillofacial surgeon with more than 25 years of experience. A graduate of New Jersey Medical School and NYU College of Dentistry, he is part of a select group of individuals with both dental and medical degrees. He completed a residency in oral and maxillofacial surgery at the University of Medicine and Dentistry of New Jersey. His practice reflects a meticulous, patient-centered approach, offering the full scope of oral surgery with a particular focus on bone regeneration of challenging defects and advanced dental implant surgery.  As the founder of New York Oral & Maxillofacial Surgery Dental Implant Center, he blends patient experience with clinical innovation.

Dr. Stein holds teaching and hospital appointments at Columbia University Medical Center. A published author and nationally recognized lecturer, he continues to advance the field of implant and reconstructive surgery through research, education, mentorship, and cutting-edge surgical practice.

About MAX Surgical Specialty Management
Founded in 2022, MAX Surgical Specialty Management is redefining the future of oral and maxillofacial surgery. A surgeon-led management services organization (MSO), MAX empowers clinical leaders to thrive by offering robust operational support, advanced technology, and a network of elite peers—while safeguarding the autonomy and identity of every practice.

With a growing footprint across New Jersey, New York, Pennsylvania, Connecticut, and Vermont, MAX is committed to building a better model: one that elevates patient care, drives professional growth, and delivers sustainable success for surgeons.

MAX is backed by MedEquity Capital, RF Investment Partners, and Kian Capital.

Learn more at www.max-ssm.com

About Our Investors

MedEquity Capital
A healthcare-focused private equity firm based in Wellesley, Mass., MedEquity has deployed over $400 million in capital across successful lower-middle-market health care investments. www.medequity.com

RF Investment Partners
A relationship-first investment firm with ~$700 million under management, RF provides flexible capital to founder-led companies in health care, software, and business services. www.rf-partners.com

Kian Capital
Recognized for five consecutive years on Inc.'s Founder-Friendly Investors list, Kian manages over $1 billion in assets and focuses on transformative growth partnerships across four core sectors. www.kiancapital.com

SOURCE MAX Surgical Specialty Management